Zifan Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zifan Zhao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Haibin Xia
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China
1 shared publicationJiaming Zhao
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China
1 shared publicationJing Gu
The Affiliated Tai’ an City Central Hospital of Qingdao University, Tai’ an, China
1 shared publication- Jing Zhang
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine, Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China
1 shared publication Minghui Xia
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China
1 shared publication- Qin Zhao
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology Wuhan University Wuhan China
1 shared publication
Latest Publications
- Open Access
- 28 October 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1685907
From “immune silence” to “immune dialogue”: modification strategies for bone substitutes based on bone immunomodulatory characteristics
Traditional bone substitute materials primarily employ a strategy centered on the direct modulation of osteoblast differentiation. However, this strategy, to some extent, overlooks the pivotal regulatory role of the immune microenvironment in the process of bone regeneration. With the continuous advancement of bone biology research, the significant regulatory role of the immune microenvironment in the osteogenic process has gradually been substantiated. Osteoimmunology studies reveal that immune cells dynamically coordinate the osteoblast-osteoclast balance through shared signaling networks. The “immune-silent” characteristic of traditional bone substitute materials often leads to fibrous encapsulation and failure of osseointegration at the surgical site. Conversely, the research focus of the new generation of bone substitute materials is centered on dynamic immune interaction strategies: by optimizing surface topology to guide macrophages toward a reparative polarization; leveraging the temporal release of bioactive ions to precisely regulate the balance between inflammation and regeneration; and integrating intelligent response systems to dynamically adapt to changes in the pathological microenvironment. Through the synergistic effects of these multifaceted approaches, the ultimate goal is to effectively promote bone tissue regeneration. Against this backdrop, this paper proposes a transition strategy from “immune silence” to “immune dialogue,” which emphasizes the active and effective modulation of immune responses through meticulous material design, thereby reshaping the bone microenvironment to create favorable conditions for bone tissue repair and reconstruction. This innovative concept breaks through the limitations of traditional unidirectional osteogenic modulation, successfully establishing a two-way dialogue bridge between bone substitute materials and the immune system, significantly improving the efficiency of clinical bone defect repair, while also greatly enhancing patient satisfaction. This review systematically outlines the latest advancements in the fields of osteoimmunology and biomaterials, focusing on the key scientific issue of “osteogenic differentiation regulated by the osteoimmune microenvironment,” and provides an in-depth analysis of biomaterial design strategies based on the dynamic balance of the immune microenvironment. The aim is to elucidate the immune-metabolic modulation mechanisms mediated by materials, thereby enhancing the clinical translation efficacy of biomaterials, and provide theoretical support and technical pathways for the precise repair of bone defects.
- 28 October 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1685907
Open AccessFrom “immune silence” to “immune dialogue”: modification strategies for bone substitutes based on bone immunomodulatory characteristics
Traditional bone substitute materials primarily employ a strategy centered on the direct modulation of osteoblast differentiation. However, this strategy, to some extent, overlooks the pivotal regulatory role of the immune microenvironment in the process of bone regeneration. With the continuous advancement of bone biology research, the significant regulatory role of the immune microenvironment in the osteogenic process has gradually been substantiated. Osteoimmunology studies reveal that immune cells dynamically coordinate the osteoblast-osteoclast balance through shared signaling networks. The “immune-silent” characteristic of traditional bone substitute materials often leads to fibrous encapsulation and failure of osseointegration at the surgical site. Conversely, the research focus of the new generation of bone substitute materials is centered on dynamic immune interaction strategies: by optimizing surface topology to guide macrophages toward a reparative polarization; leveraging the temporal release of bioactive ions to precisely regulate the balance between inflammation and regeneration; and integrating intelligent response systems to dynamically adapt to changes in the pathological microenvironment. Through the synergistic effects of these multifaceted approaches, the ultimate goal is to effectively promote bone tissue regeneration. Against this backdrop, this paper proposes a transition strategy from “immune silence” to “immune dialogue,” which emphasizes the active and effective modulation of immune responses through meticulous material design, thereby reshaping the bone microenvironment to create favorable conditions for bone tissue repair and reconstruction. This innovative concept breaks through the limitations of traditional unidirectional osteogenic modulation, successfully establishing a two-way dialogue bridge between bone substitute materials and the immune system, significantly improving the efficiency of clinical bone defect repair, while also greatly enhancing patient satisfaction. This review systematically outlines the latest advancements in the fields of osteoimmunology and biomaterials, focusing on the key scientific issue of “osteogenic differentiation regulated by the osteoimmune microenvironment,” and provides an in-depth analysis of biomaterial design strategies based on the dynamic balance of the immune microenvironment. The aim is to elucidate the immune-metabolic modulation mechanisms mediated by materials, thereby enhancing the clinical translation efficacy of biomaterials, and provide theoretical support and technical pathways for the precise repair of bone defects.
- Open Access
- 16 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1962
Biodegradation of HA and β-TCP Ceramics Regulated by T-Cells
Biodegradability is one of the most important properties of implantable bone biomaterials, which is directly related to material bioactivity and the osteogenic effect. How foreign body giant cells (FBGC) involved in the biodegradation of bone biomaterials are regulated by the immune system is poorly understood. Hence, this study found that β-tricalcium phosphate (β-TCP) induced more FBGCs formation in the microenvironment (p = 0.0061) accompanied by more TNFα (p = 0.0014), IFNγ (p = 0.0024), and T-cells (p = 0.0029) than hydroxyapatite (HA), resulting in better biodegradability. The final use of T-cell depletion in mice confirmed that T-cell-mediated immune responses play a decisive role in the formation of FBGCs and promote bioceramic biodegradation. This study reveals the biological mechanism of in vivo biodegradation of implantable bone tissue engineering materials from the perspective of material-immune system interaction, which complements the mechanism of T-cells’ adaptive immunity in bone immune regulation and can be used as a theoretical basis for rational optimization of implantable material properties.
- 16 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1962
Open AccessBiodegradation of HA and β-TCP Ceramics Regulated by T-Cells
Biodegradability is one of the most important properties of implantable bone biomaterials, which is directly related to material bioactivity and the osteogenic effect. How foreign body giant cells (FBGC) involved in the biodegradation of bone biomaterials are regulated by the immune system is poorly understood. Hence, this study found that β-tricalcium phosphate (β-TCP) induced more FBGCs formation in the microenvironment (p = 0.0061) accompanied by more TNFα (p = 0.0014), IFNγ (p = 0.0024), and T-cells (p = 0.0029) than hydroxyapatite (HA), resulting in better biodegradability. The final use of T-cell depletion in mice confirmed that T-cell-mediated immune responses play a decisive role in the formation of FBGCs and promote bioceramic biodegradation. This study reveals the biological mechanism of in vivo biodegradation of implantable bone tissue engineering materials from the perspective of material-immune system interaction, which complements the mechanism of T-cells’ adaptive immunity in bone immune regulation and can be used as a theoretical basis for rational optimization of implantable material properties.